CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Cost of Goods Sold (Deprecated 2018-01-31)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Cost of Goods Sold (Deprecated 2018-01-31) of $68.69 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2018-05-10
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $68.69M, a 2.15% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-30 was $86.01M, a 18.21% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $67.66M, a 2.41% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-07-01 was $68.75M, a 0.83% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $289.67M, a 4.56% increase from fiscal 2016.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $277.03M, a 4.94% increase from fiscal 2015.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $263.98M, a 0.92% decline from fiscal 2014.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $266.42M, a 2.32% decline from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2018-03-31 | $68.69M 10-Q · filed 2018-05-10 | $154.71M derived: sum of 2 quarters · filed 2018-05-10 | $222.37M derived: sum of 3 quarters · filed 2018-05-10 | $291.12M derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2017-12-30 | $86.01M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $153.67M derived: sum of 2 quarters · filed 2018-02-13 | $222.43M derived: sum of 3 quarters · filed 2018-02-13 | $289.67M 10-K · filed 2018-02-13 | |||
| 2017-09-30 | $67.66M 10-Q · filed 2017-11-09 | $136.41M derived: sum of 2 quarters · filed 2017-11-09 | $203.66M 10-Q · filed 2017-11-09 | $276.42M derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2017-07-01 | $68.75M 10-Q · filed 2017-08-09 | $136.00M 10-Q · filed 2017-08-09 | $208.76M derived: sum of 3 quarters · filed 2018-05-10 | $278.09M derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2017-04-01 | $67.24M 10-Q · filed 2018-05-10 | $140.01M derived: sum of 2 quarters · filed 2018-05-10 | $209.34M derived: sum of 3 quarters · filed 2018-05-10 | $277.53M derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2016-12-31 | $72.76M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $142.10M derived: sum of 2 quarters · filed 2018-02-13 | $210.28M derived: sum of 3 quarters · filed 2018-02-13 | $277.03M 10-K · filed 2018-02-13 | |||
| 2016-09-24 | $69.33M 10-Q · filed 2017-11-09 | $137.52M derived: sum of 2 quarters · filed 2017-11-09 | $204.27M 10-Q · filed 2017-11-09 | $274.93M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-06-25 | $68.19M 10-Q · filed 2017-08-09 | $134.94M 10-Q · filed 2017-08-09 | $205.60M derived: sum of 3 quarters · filed 2018-02-13 | $271.83M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-03-26 | $66.75M 10-Q · filed 2017-05-10 | $137.41M derived: sum of 2 quarters · filed 2018-02-13 | $203.64M derived: sum of 3 quarters · filed 2018-02-13 | $266.29M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2015-12-26 | $70.66M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $136.89M derived: sum of 2 quarters · filed 2018-02-13 | $199.53M derived: sum of 3 quarters · filed 2018-02-13 | $263.98M 10-K · filed 2018-02-13 | |||
| 2015-09-26 | $66.22M 10-Q · filed 2016-11-02 | $128.87M derived: sum of 2 quarters · filed 2016-11-02 | $193.32M 10-Q · filed 2016-11-02 | $260.32M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-06-27 | $62.65M 10-Q · filed 2016-08-03 | $127.09M 10-Q · filed 2016-08-03 | $194.10M derived: sum of 3 quarters · filed 2017-02-14 | $259.34M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-03-28 | $64.45M 10-Q · filed 2016-05-04 | $131.45M derived: sum of 2 quarters · filed 2017-02-14 | $196.69M derived: sum of 3 quarters · filed 2017-02-14 | $264.29M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2014-12-27 | $67.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $132.25M derived: sum of 2 quarters · filed 2017-02-14 | $199.84M derived: sum of 3 quarters · filed 2017-02-14 | $266.42M 10-K · filed 2017-02-14 | |||
| 2014-09-27 | $65.25M 10-Q · filed 2015-11-04 | $132.84M derived: sum of 2 quarters · filed 2015-11-04 | $199.42M 10-Q · filed 2015-11-04 | $269.22M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-06-28 | $67.59M 10-Q · filed 2015-07-30 | $134.18M 10-Q · filed 2015-07-30 | $203.97M derived: sum of 3 quarters · filed 2016-02-12 | $274.27M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-03-29 | $66.59M 10-Q · filed 2015-04-30 | $136.38M derived: sum of 2 quarters · filed 2016-02-12 | $206.68M derived: sum of 3 quarters · filed 2016-02-12 | $273.30M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2013-12-28 | $69.80M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $140.09M derived: sum of 2 quarters · filed 2016-02-12 | $206.72M derived: sum of 3 quarters · filed 2016-02-12 | $272.75M 10-K · filed 2016-02-12 | $272.30M 10-K · filed 2014-02-25 | ||
| 2013-09-28 | $70.29M 10-Q · filed 2014-10-30 | $136.92M derived: sum of 2 quarters · filed 2014-10-30 | $202.95M 10-Q · filed 2014-10-30 | $270.03M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2013-06-29 | $66.63M 10-Q · filed 2014-08-07 | $132.66M 10-Q · filed 2014-08-07 | $199.74M derived: sum of 3 quarters · filed 2015-02-17 | $263.39M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2013-03-30 | $66.03M 10-Q · filed 2014-04-30 | $133.11M derived: sum of 2 quarters · filed 2015-02-17 | $196.76M derived: sum of 3 quarters · filed 2015-02-17 | $258.80M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2012-12-29 | $67.08M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $130.73M derived: sum of 2 quarters · filed 2015-02-17 | $192.76M derived: sum of 3 quarters · filed 2015-02-17 | $257.71M 10-K · filed 2015-02-17 | $255.41M 10-K · filed 2013-02-27 | ||
| 2012-09-29 | $63.65M 10-Q · filed 2013-10-30 | $125.68M derived: sum of 2 quarters · filed 2013-10-30 | $190.63M 10-Q · filed 2013-10-30 | $261.19M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-06-30 | $62.03M 10-Q · filed 2013-07-31 | $126.98M 10-Q · filed 2013-07-31 | $197.54M derived: sum of 3 quarters · filed 2014-02-25 | $263.91M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-03-31 | $64.94M 10-Q · filed 2013-05-08 | $135.51M derived: sum of 2 quarters · filed 2014-02-25 | $201.87M derived: sum of 3 quarters · filed 2014-02-25 | $267.14M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2011-12-31 | $70.56M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $136.93M derived: sum of 2 quarters · filed 2014-02-25 | $202.20M derived: sum of 3 quarters · filed 2014-02-25 | $267.97M 10-K · filed 2014-02-25 | |||
| 2011-09-24 | $66.37M 10-Q · filed 2012-11-01 | $131.64M derived: sum of 2 quarters · filed 2012-11-01 | $197.41M 10-Q · filed 2012-11-01 | $261.81M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-06-25 | $65.27M 10-Q · filed 2012-08-07 | $131.04M 10-Q · filed 2012-08-07 | $195.45M derived: sum of 3 quarters · filed 2013-02-27 | $257.62M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-03-26 | $65.77M 10-Q · filed 2012-05-04 | $130.18M derived: sum of 2 quarters · filed 2013-02-27 | $192.35M derived: sum of 3 quarters · filed 2013-02-27 | $255.01M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2010-12-25 | $64.41M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $126.58M derived: sum of 2 quarters · filed 2013-02-27 | $189.24M derived: sum of 3 quarters · filed 2013-02-27 | $252.96M 10-K · filed 2013-02-27 | |||
| 2010-09-25 | $62.18M 10-Q · filed 2011-11-02 | $62.17M 10-Q · filed 2010-11-04 | $124.83M derived: sum of 2 quarters · filed 2011-11-02 | $188.55M 10-Q · filed 2011-11-02 | $254.07M derived: sum of 4 quarters · filed 2012-02-27 | ||
| 2010-06-26 | $62.66M 10-Q · filed 2011-08-03 | $126.38M 10-Q · filed 2011-08-03 | $126.38M 10-Q · filed 2010-08-03 | $191.89M derived: sum of 3 quarters · filed 2012-02-27 | $254.31M derived: sum of 4 quarters · filed 2012-02-27 | ||
| 2010-03-27 | $63.72M 10-Q · filed 2011-05-04 | $129.24M derived: sum of 2 quarters · filed 2012-02-27 | $191.65M derived: sum of 3 quarters · filed 2012-02-27 | $256.07M derived: sum of 4 quarters · filed 2012-02-27 | |||
| 2009-12-26 | $65.51M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $127.93M derived: sum of 2 quarters · filed 2012-02-27 | $192.35M derived: sum of 3 quarters · filed 2012-02-27 | $255.68M 10-K · filed 2012-02-27 | |||
| 2009-09-26 | $62.42M 10-Q · filed 2010-11-04 | $126.83M derived: sum of 2 quarters · filed 2010-11-04 | $190.17M 10-Q · filed 2010-11-04 | ||||
| 2009-06-27 | $64.42M 10-Q · filed 2010-08-03 | $127.75M 10-Q · filed 2010-08-03 | |||||
| 2008-12-27 | $252.94M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |